DuoGenic StemCells Corporation (7607) Financial Statements
DuoGenic StemCells Corporation Financial Overview
DuoGenic StemCells Corporation's market cap is currently TWD438.00M. The company's EPS TTM is TWD-1.02; its P/E ratio is -11.67; DuoGenic StemCells Corporation has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | TWD 20.69M | TWD 12.05M | TWD 13.67M | TWD 6.86M | TWD 2.30M |
| Gross Profit | TWD 15.79M | TWD 4.10M | TWD 4.90M | TWD -452.00K | TWD -4.98M |
| Operating Income | TWD -25.79M | TWD -61.01M | TWD -44.88M | TWD -33.42M | TWD -23.14M |
| EBITDA | TWD -19.63M | TWD -53.77M | TWD -37.90M | TWD -28.33M | TWD -20.13M |
| Net Income | TWD -26.38M | TWD -61.58M | TWD -45.24M | TWD -34.05M | TWD -21.98M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | TWD 49.73M | TWD 25.07M | TWD 46.30M | TWD 42.81M | TWD 51.41M |
| Total Assets | TWD 78.54M | TWD 59.65M | TWD 94.00M | TWD 82.24M | TWD 74.11M |
| Total Debt | TWD 22.22M | TWD 35.81M | TWD 7.17M | TWD 2.74M | TWD 1.55M |
| Net Debt | TWD -27.51M | TWD 10.74M | TWD -39.13M | TWD -40.07M | TWD -49.86M |
| Total Liabilities | TWD 27.55M | TWD 42.81M | TWD 15.58M | TWD 8.62M | TWD 4.44M |
| Stockholders' Equity | TWD 50.99M | TWD 16.84M | TWD 78.42M | TWD 73.62M | TWD 69.67M |
| Cash Flow | |||||
| Free Cash Flow | TWD -18.73M | TWD -48.52M | TWD -44.66M | TWD -45.47M | TWD -29.05M |
| Operating Cash Flow | TWD -18.47M | TWD -47.31M | TWD -43.66M | TWD -33.42M | TWD -20.04M |
| Investing Cash Flow | TWD -4.90M | TWD -1.21M | TWD -1.00M | TWD -12.04M | TWD -9.01M |
| Financing Cash Flow | TWD 48.04M | TWD 27.29M | TWD 48.15M | TWD 36.86M | TWD 62.43M |
Currency in TWD
